Trial Profile

Long-term Effects of Inhaled Corticosteroids (ICS) Treatment on Sputum Bacterial and Viral Loads in COPD Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Salmeterol/fluticasone propionate (Primary) ; Salmeterol
Indications Chronic obstructive pulmonary disease
Focus Pharmacodynamics; Proof of concept
Acronyms PROBE

Most Recent Events

01 Oct 2017 Results published in the European Respiratory Journal
01 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
08 Oct 2010 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com